Bromantane for Fat Loss
Russian actoprotectant adamantane; mild dopaminergic stimulant approved for asthenia.
Why Bromantane for fat loss?
Bromantane (Ladasten) is an adamantane-derived 'actoprotector' developed in the USSR and approved in Russia for asthenic disorders. It increases dopamine synthesis via tyrosine-hydroxylase upregulation and is on the WADA prohibited list. It is not a peptide but is grouped with nootropics in many libraries.
Fat Loss context: Reducing body fat percentage through appetite regulation, lipolysis, or metabolic upregulation. Bromantane fits this goal because its category (Cognitive) and benefit profile align with the underlying mechanism.
Benefits relevant to fat loss
- Anti-fatigue without classical stimulant comedown
Reference dosing by bodyweight
Anchored to the most-cited research dose (50000 mcg @ 75 kg). Reference only.
| Bodyweight band | Reference dose range |
|---|---|
| <60 kg / <132 lb | 31167–42167 mcg |
| 60–75 kg / 132–165 lb | 38250–51750 mcg |
| 75–90 kg / 165–198 lb | 46750–63250 mcg |
| 90–105 kg / 198–231 lb | 55250–74750 mcg |
| >105 kg / >231 lb | 63750–86250 mcg |
Side effects to weigh against fat loss benefit
- Insomnia if dosed late
- Mild GI upset
- Rare headache
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.